FY2025 · ended Dec 31, 2025 · Revenue $20.62B, +4.8% YoY · Filed Feb 4, 2026
Ge Healthcare Technologies Inc. (GEHC) files with the SEC under industry code 3844, X-Ray Apparatus & Tubes & Related Irradiation Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $20.6 billion and net income of $2.1 billion. Free cash flow was $1.5 billion. As of Sep 30, 2026 it held $3.2 billion in cash and investments and $10.4 billion in total debt.
Revenue (TTM)
$21.64B
+6.9% vs year-ago TTM
Net income (TTM)
$2.15B
-2.8% vs year-ago TTM
Operating cash flow
$1.99B
+1.6% vs prior year
Free cash flow
$1.50B
-3.2% vs prior year
EPS (TTM)
$4.72
-2.3% vs year-ago TTM
Dividend per share (TTM)
$0.15
+3.6% vs year-ago TTM
Shares outstanding
455.75M
-0.3% vs prior year
Net cash
$-7.20B
as of Sep 30, 2026
Operating margin
13.3%
FY 2026
Company profile
- Industry
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844)
- Listed as
- GEHC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Chicago, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1932393
- Former names
- GE Healthcare Holding LLC (until Dec 14, 2022)
Other X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies
- Koninklijke Philips NV PHG
- Butterfly Network, Inc. BFLY
- Nano-X Imaging Ltd. NNOX
All 4 X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Revenue | $20.6B | $19.7B | $19.6B |
| Operating income | $2.8B | $2.6B | $2.4B |
| Net income | $2.1B | $2.0B | $1.6B |
| Diluted EPS | $4.55 | $4.34 | $3.03 |
| Operating cash flow | $2.0B | $2.0B | $2.1B |
| Free cash flow | $1.5B | $1.6B | $1.7B |
| Total assets | $36.9B | $33.1B | $32.5B |
| Total liabilities | $26.3B | $24.4B | $25.1B |
| Stockholders' equity | $10.4B | $8.4B | $7.1B |
| Cash and investments | $4.8B | $3.2B | $2.9B |
| Total debt | $11.0B | $10.9B | $10.9B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 5, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Oct 28, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 18, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
All 446 Ge Healthcare Technologies Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.